Featured Research

from universities, journals, and other organizations

Physician Suggests Possible Enzyme Deficiency In Cystic Fibrosis

Date:
June 25, 2003
Source:
University Of Iowa
Summary:
Mucus that excessively accumulates in the lungs of patients with cystic fibrosis (CF) may be linked to the deficiency of an enzyme called arylsulfatase B. The deficiency may in turn be linked to the known genetic mutation in CF -- a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Mucus that excessively accumulates in the lungs of patients with cystic fibrosis (CF) may be linked to the deficiency of an enzyme called arylsulfatase B. The deficiency may in turn be linked to the known genetic mutation in CF -- a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

The possible connection is proposed by Joanne Tobacman, M.D., University of Iowa assistant professor (clinical) of internal medicine, who reviewed 30 years of research about the enzyme and chemicals it normally metabolizes, or processes for use by the body. Tobacman's opinion article appears in the June 6 issue of CHEST: The Cardiopulmonary and Critical Care Journal of the American College of Chest Physicians.

"The CFTR gene is mutated in people with CF but the observed manifestations of the disease have not been fully explained by that genetic change," Tobacman said. "Mutations in the CFTR gene might reduce the arylsulfatase B activity."

The CFTR defect is known to alter a protein, causing problems in cellular channels that normally regulate salt and water secretions. The defective CFTR protein also affects other cellular processes. The first CFTR gene discovery was made in 1989. Tobacman drew on an even earlier observation by another researcher to draw a possible connection between CFTR and arylsulfatase B.

In 1970, Elizabeth Neufeld, Ph.D., formerly a researcher with the National Institutes of Health (now professor and chair of biological chemistry at the University of California at Los Angeles), found diminished sulfatase enzyme activity in the lymphoid cells lines of patients with CF.

Normally, arylsulfatase B metabolizes two sugar chains called dermatan sulfate and chondroitin-4 sulfate. However, when arylsulfatase B is absent or insufficient, these substances can build up and change the characteristics of secretions.

"These sulfated glycosaminoglycans, or GAGs can accumulate, altering the properties of secretions and making it more difficult to clear them," Tobacman said. "This predisposes people with CF to chronic infection."

Pseudomonas, a bacteria that often infects people with CF, makes sulfatase and may utilize the GAGs that are not metabolized because of insufficient arylsulfatase B. Thus, the extra GAGs may help this bacteria flourish.

Tobacman also noted that CF shares a few clinical characteristics with the recessive genetic disease Maroteaux-Lamy Syndrome, which is caused by complete or severe arylsulfatase B deficiency.

The article is accompanied by an editorial by Bruce Rubin, M.D., professor of pediatrics, medicine, medical engineering, physiology and pharmacology at Wake Forest University School of Medicine. Rubin writes, "CFTR is a large and complex channel, so it is not surprising that it would have diverse functions. The link between these functions of CFTR and CF disease remains a matter of speculation and debate."

The next step for Tobacman and colleagues will be to assess the impact of CFTR gene transfection on arylsulfatase B activity in CF cell lines. Transfection involves introducing a functional copy of the gene. Tobacman also will further explore the effect of sulfatase enzymes in clinical conditions. The chemical name of arylsulfatase B is N-acetylgalactosamine-4-sulfatase.

University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at http://www.uihealthcare.com.


Story Source:

The above story is based on materials provided by University Of Iowa. Note: Materials may be edited for content and length.


Cite This Page:

University Of Iowa. "Physician Suggests Possible Enzyme Deficiency In Cystic Fibrosis." ScienceDaily. ScienceDaily, 25 June 2003. <www.sciencedaily.com/releases/2003/06/030625091220.htm>.
University Of Iowa. (2003, June 25). Physician Suggests Possible Enzyme Deficiency In Cystic Fibrosis. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2003/06/030625091220.htm
University Of Iowa. "Physician Suggests Possible Enzyme Deficiency In Cystic Fibrosis." ScienceDaily. www.sciencedaily.com/releases/2003/06/030625091220.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins